 |
市場調查報告書
商品編碼
1705653
全球醫藥市場人工智慧（AI）的部署模式、產品、技術、藥物類型、應用、最終用戶和地區Global Artificial Intelligence (AI) In Pharmaceutical Market, By Deployment Mode, By Offering, By Technology, By Drug Type, By Application, By End User, By Geography |
||||||
價格
簡介目錄
2025 年全球人工智慧 (AI) 醫藥市場規模估計為 14.661 億美元，預計到 2032 年將達到 104.069 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 32.3%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025年的市場規模 | 14.661億美元 |
| 效能數據 | 2020-2024 | 預測期 | 2025-2032 |
| 預測期：2025-2032年複合年成長率： | 32.30% | 2032年價值預測 | 104.069億美元 |
數字。 2025年全球市場佔有率（%）
人工智慧 (AI) 已成為一項變革性技術，它將徹底改變製藥業。透過利用大量數據和複雜演算法，人工智慧有可能幫助製藥公司加速藥物研發、簡化臨床試驗並實現更準確的診斷和治療。人工智慧透過快速分析大量資料集並識別可能帶來新治療方法的關係，增強了製藥科學家的工作能力。人工智慧使研究人員能夠以前所未有的規模和速度分析基因序列資訊和電子健康記錄。該技術可以幫助發現新的治療方法並預測重新利用現有藥物治療其他疾病的潛力。人工智慧可望增強人類的能力，提高藥物研發的效率，並更快為患者帶來創新的新藥。
市場動態：
全球人工智慧 (AI) 在醫藥市場的成長受到控制藥物發現和開發成本、縮短藥物開發週期和精準醫療進步的日益成長的需求的推動。人工智慧可以加速藥物研發，減少代價高昂的後期臨床試驗失敗，並幫助藥物更快推向市場。然而，人工智慧模型缺乏可解釋性以及對其融入決策的懷疑可能會阻礙其採用。增加藥品資料集的可用性和加強法律規範可能會提供巨大的成長機會。如果做得正確，可以克服可解釋性問題和缺乏專業知識，從而充分發揮這項創新技術的潛力。
本研究的主要特點
- 本報告對全球製藥人工智慧 (AI) 市場進行了詳細分析，並以 2024 年為基準年，展示了預測期 (2025-2032) 的市場規模和年複合成長率（CAGR%）。
- 它揭示了各個領域的潛在商機，並解釋了該市場的引人注目的投資提案矩陣。
- 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
- 全球製藥人工智慧 (AI) 市場的主要企業已根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數進行了分析。
- 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
- 全球製藥業人工智慧 (AI) 市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
- 相關人員可以透過分析全球製藥業人工智慧 (AI) 市場中使用的各種策略矩陣來簡化決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章市場動態、法規與趨勢分析
- 市場動態
- 驅動程式
- 限制因素
- 機會
- 影響分析
- 市場趨勢
- 主要進展
- 監管情景
- 收購與合作場景
- 資金籌措與投資
- PEST分析
- 波特分析
第4章。全球製藥市場人工智慧（AI）-冠狀病毒（COVID-19）大流行的影響
- 整體影響
- 政府舉措
- COVID-19 市場影響
5. 2021 年至 2032 年全球製藥業人工智慧 (AI) 市場（依部署模式）
- 雲
- 本地
6. 2021 年至 2032 年全球製藥業人工智慧 (AI) 市場
- 硬體
- 軟體
- 服務
7. 2021 年至 2032 年全球製藥業人工智慧 (AI) 市場（按技術分類）
- 自然語言處理
- 情境感知處理
- 深度學習
- 查詢方法
- 其他
8. 2021 年至 2032 年全球製藥業人工智慧 (AI) 市場（按藥物類型）
- 大分子
- 小分子
第9章。 2021 年至 2032 年全球製藥業人工智慧 (AI) 市場應用狀況
- 藥物研發
- 臨床試驗
- 研究與開發
- 醫藥製造與供應鏈
- 其他
第 10 章。 2021 年至 2032 年，全球製藥業人工智慧 (AI) 市場（按最終用戶分類）
- 製藥和生物技術公司
- 醫院和診斷中心
- 學術研究所
- 其他
第 11 章。 2021 年至 2032 年按地區分類的全球製藥人工智慧 (AI) 市場
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第12章競爭格局
- 公司簡介
- NVIDIA Corporation
- IBM Corporation
- Exscientia
- Insilico Medicine
- Atomwise, Inc.
- Cloud Pharmaceuticals, Inc.
- Cyclica Inc.
- Envisagenics, Inc.
- Numerate, Inc.
- Schrodinger, Inc.
- Standigm
- Turbine.ai
- BenevolentAI
- Recursion Pharmaceuticals
- Owkin, Inc.
- XtalPi Inc.
- Valo Health
- Absci
第 13 章分析師建議
- 命運之輪
- 分析師觀點
- 一致的機會圖
第14章參考文獻與調查方法
- 參考
- 調查方法
簡介目錄
Product Code: CMI7209
Global Artificial Intelligence (AI) In Pharmaceutical Market is estimated to be valued at USD 1,466.1 Mn in 2025 and is expected to reach USD 10,406.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 32.3% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 1,466.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 32.30% | 2032 Value Projection: | USD 10,406.9 Mn |
Figure. Global Artificial Intelligence (AI) In Pharmaceutical Market Share (%), By Region 2025
Artificial intelligence (AI) has emerged as a transformative technology that is poised to revolutionize the pharmaceutical industry. By leveraging huge amounts of data and sophisticated algorithms, AI has the potential to help drug makers to accelerate drug discovery, streamline clinical trials and enable more precise diagnosis and treatment. AI augments the work of pharmaceutical scientists by swiftly analyzing huge datasets to identify relationships that may lead to new therapies. With AI, researchers can analyze genetic sequencing information or electronic health records at an unprecedented scale and speed. The technology helps discover new therapies and predict which existing drugs could be repurposed to treat other conditions. AI promises to augment human capabilities, make pharmaceutical R&D more efficient and bring innovative new medicines to patients faster.
Market Dynamics:
Global artificial intelligence (AI) in pharmaceutical market growth is driven by rising need to control drug discovery and development costs, reduce the drug development cycle time and advance precision medicine. AI can accelerate drug discovery, reduce expensive late-stage clinical trial failures and help launch drugs faster. However, lack of interpretability of AI models and skepticism about integrating it into decision-making can hamper its adoption. Growing availability of pharma data sets and encouraging regulatory frameworks can offer significant growth opportunities. If addressed properly, interpretability issues and lack of expertise can be overcome to extract full potential from this transformative technology.
Key Features of the Study:
- This report provides in-depth analysis of the global artificial intelligence (AI) in pharmaceutical market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global artificial intelligence (AI) in pharmaceutical market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include IBM, Microsoft, AWS, Google, Anthropic, Berg Health and InSilico Medicine
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global artificial intelligence (AI) in pharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence (AI) in pharmaceutical market
Detailed Segmentation-
- By Deployment Mode
- Cloud
- On-Premise
- By Offering
- Hardware
- Software
- Services
- By Technology
- Natural Language Processing
- Context-Aware Processing
- Deep Learning
- Querying Method
- Other
- By Drug Type
- Large Molecules
- Small Molecules
- By Application
- Drug Discovery
- Clinical Trial
- Research & Development
- Drug Manufacturing and Supply Chain
- Others
- By End User
- Pharmaceutical & Biotechnology Companies
- Hospitals and Diagnostic Centers
- Academic & Research Institutes
- Others
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- NVIDIA Corporation
- IBM Corporation
- Exscientia
- Insilico Medicine
- Atomwise, Inc.
- Cloud Pharmaceuticals, Inc.
- Cyclica Inc.
- Envisagenics, Inc.
- Numerate, Inc.
- Schrodinger, Inc.
- Standigm
- ai
- BenevolentAI
- Recursion Pharmaceuticals
- Owkin, Inc.
- XtalPi Inc.
- Valo Health
- Absci
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Deployment Mode
- Market Snapshot, By Offering
- Market Snapshot, By Technology
- Market Snapshot, By Drug Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Artificial Intelligence (AI) in Pharmaceutical Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Deployment Mode, 2021 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cloud
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- On-Premise
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Offering, 2021 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hardware
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Software
- Mammography
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Services
- Chest X-ray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Technology, 2021 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Natural Language Processing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Context-Aware Processing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Deep Learning
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Querying Method
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Drug Type, 2021 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Large Molecules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Small Molecules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
9. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Application, 2021 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Drug Discovery
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Clinical Trial
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Research & Development
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Drug Manufacturing and Supply Chain
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
10. Global Artificial Intelligence (AI) in Pharmaceutical Market, By End User, 2021 - 2032, (USD Mn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmaceutical & Biotechnology Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Hospitals and Diagnostic Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
11. Global Artificial Intelligence (AI) in Pharmaceutical Market, By Region, 2021 - 2032, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Deployment Mode, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Offering, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2032, (USD Mn)
- North Africa
- Central Africa
- South Africa
12. Competitive Landscape
- Company Profiles
- NVIDIA Corporation
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- IBM Corporation
- Exscientia
- Insilico Medicine
- Atomwise, Inc.
- Cloud Pharmaceuticals, Inc.
- Cyclica Inc.
- Envisagenics, Inc.
- Numerate, Inc.
- Schrodinger, Inc.
- Standigm
- Turbine.ai
- BenevolentAI
- Recursion Pharmaceuticals
- Owkin, Inc.
- XtalPi Inc.
- Valo Health
- Absci
- NVIDIA Corporation
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
